Sano Genetics/X
Jul 31, 2025, 15:37
Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab
Sano Genetics shared an inviting post on X:
”Tune in to Episode 198 of The Genetics Podcast.
This week, we’re joined by Benny Sorensen, CEO of Hemab Therapeutics. Tune in to hear about how Benny’s persistence and “unreasonable” leadership led to Hemab’s first program, how Hemab is reimagining clotting therapies by centering patient voices, and the value of their multi-modality and collaborative approach.”
Listen to the Apple Podcast here.
Listen to the YouTube Podcast here.
Stay tuned with Hemostasis Today.
-
Mar 27, 2026, 16:46Anita Brikman: Expanding Access to Plasma-Derived Medicines in India
-
Mar 27, 2026, 16:26Robert Talac: Platelet Concentration Gap – PRP vs Advanced PRF
-
Mar 27, 2026, 16:23Nathan Wong: Lp(a) Testing as a Class I Recommendation in 2026 Guidelines
-
Mar 27, 2026, 16:21Jeff Sternlicht: Inflammation is The ‘Storm’ Before Atherosclerosis
-
Mar 27, 2026, 16:19Laura Baglow-Micic: Register for the Transfusion Research Network for The SWiFT Trial Results Webinar
-
Mar 27, 2026, 16:18Chris Hannay: Rising Demand for Immunoglobulin Driving Plasma Industry Growth in Canada
-
Mar 27, 2026, 15:33Caitlin Raymond: A Manifesto on Three Foundational Values for a Real Culture of Wellness
-
Mar 27, 2026, 15:30Shankar Biswas: Impact of Coronary Collaterals on Mortality in STEMI
-
Mar 27, 2026, 15:21Joseph Ebubechukwu: The Hidden Impact of Elevated PCV on Patient Wellbeing